Changes in gene regulation during differentiation are governed by networks of transcription factors. To identify the minimal network for endodermal differentiation in the Arabidopsis root, we asked what transcription factors are sufficient to program a non-native celltype into endodermis. Our results show the transcription factors SHORTROOT and MYB36
suberin (11) . We conclude that SHR and MYB36, but not SCR, are able to stochastically generate endodermal features in the epidermis.
The ectopic Casparian strip-like structures in the epidermis do not resemble the native Casparian strip. Instead, they have a "beads on a string" phenotype similar to the sgn3 receptor mutant ( Fig. 1 G-H) (13) . It was previously reported that SGN3 expression is significantly downregulated in shr but is relatively unaffected in scr or myb36 (10, 14) . Recently, the peptide CIF2 was identified as a ligand for SGN3. CIF2 is produced in the stele and its expression is independent of SHR (14) . We hypothesized that the "beads on a string" phenotype of the ectopic Casparian strip-like structures was a result of present but inactive SGN3 as CIF2 would not be able to reach the epidermal cell layer from the stele. To test this hypothesis, we treated epidermal-expressed SHR seedlings with 100 nM CIF2. This treatment resolved the "beads on a string" phenotype, however, the addition of CIF2 also induced polarized CASP1 in 80-100% of the cells in the sub-epidermal layer ( Fig. 2A-B ). These cells also deposit lignin ( Fig. 2C -D) and suberin ( Fig. S2A-B ). We confirmed that cells ectopically expressing SHR can induce SGN3 ( Fig. S3A -C) and that this fate change is not due to SGN3 alone, since epidermal-expressed SGN3 in the sgn3-3 background was not capable of reprogramming the epidermis with or without CIF2 ( Fig. S3C-F) . Ectopic Casparian Strip-like structures in epidermal-expressed MYB36 roots also have a "beads on a string" phenotype ( Fig 1H) . However, since SGN3 expression is unaffected in a myb36 mutant (10)( Fig. S3G-H) , we hypothesized that expression of MYB36 is not sufficient to activate SGN3, and thus CIF2 treatment would not seal ectopic Casparian strip-like domains. Consistent with our hypothesis, treatment with CIF2 did not seal ectopic domains nor did it induce significantly more epidermal cells to form Casparian strips We then asked if the sub-epidermal cell layer resembles an endodermis or simply produces a Casparian-strip like structure in a cortex cell. We performed RNAseq on FACSsorted mCherry-positive cells. CASP1-positive cells were analyzed from wild-type plants expressing CASP1-mCherry and from plants with epidermal-expressed SHR (pWER::SHR:GFP;CASP1-mCherry) with or without CIF2 treatment ( Fig. 2E ). Note, that in all cases, cells from the endogenous endodermis express CASP1 and thus are analyzed along with the ectopically expressing cells. However, the number of ectopically expressing cells differs dramatically with and without CIF2 in epidermal-expressing SHR lines. Interestingly, treatment with CIF2 yielded only two genes differentially expressed compared to the untreated controls in both genotypes (Table S1 ). This suggests that CIF2 acts primarily in a post-transcriptional manner on CASP1-positive cells. In a comparison of wild-type and epidermal-expressed SHR, there were 172 differentially expressed genes with both receiving CIF2 treatment and 62 differentially expressed genes without treatment ( Fig. S5 A, Table S1 ). Of the 172 differentially expressed genes, only 12 were down-regulated in epidermal-expressed SHR as compared to wild-type suggesting only a few endodermis-associated genes are missing from the reprogrammed layer (Table S1 ). Many of the genes up-regulated in the epidermal-expressed SHR lines show enriched expression in the native cortex ( Fig. S5B ), indicating that this approach has captured reprogrammed cells that retain some of their former cell state. To determine the identity of the trans-differentiated cells, we carried out a Principal component analysis comparing our obtained profiles to those from high-resolution RNAseq cell type-specific profiles (RootMap 3.0) ( Fig. S5A) (19) . The epidermal expressed SHR with CIF2 treatment clustered closely with wildtype CASP1-positive cells (no CIF2) and with the endodermis marker E30 as compared to the cortex marker COR (315.1). This suggests that the reprogrammed cells most closely resemble mature endodermal cells even though they retain a minor amount of cortex gene expression.
We also calculated an Index of Cell Identity (ICI) to characterize cell identity based on the weighted expression of marker genes defining that tissue (20) . We calculated Spec scores for marker genes using the RootMap 3.0 data, and calculated the ICI for CASP1-positive (wild-type) and epidermal-expressed SHR samples, both with and without CIF2 treatment. We found that the reprogrammed cells significantly associate with endodermal identity (E30), but retain a low, nonsignificant, level of cortex identity (COR/315.1) ( Fig. 2F ). These analyses indicate that the epidermal-expression of SHR is sufficient to reprogram to an endodermal cell fate and predominantly turn off the native cortex gene expression. Interestingly, cell fate was effectively switched in CASP1-positive cells regardless of CIF2 treatment, suggesting that CIF2 functions post-transcriptionally to stabilize cell fate.
The sporadic nature of reprogrammed epidermal cells prior to CIF2 treatment suggested that expression of the downstream targets was unstable. To analyze the dynamics of downstream targets, we live-imaged CASP1 in plants with epidermal-expressed SHR for 24 hours. We found that the ectopic CASP1 intensity fluctuates over time (Movie 1, Fig. 3A-B ). Interestingly, the CASP1-positive cells were not necessarily the same cells assembling lignin ( Fig. 3C ). This could indicate that reprogramming is not a linear process in which the steps follow a predetermined order, or could be a result of the instability of CASP1. Consistent with the stochastic expression of CASP1, SCR is also expressed in some but not all epidermal meristematic cells in epidermalexpressed SHR roots ( Fig. S5 A-C). By contrast, MYB36 expression was occasionally detectable in the epidermis, but primarily induced in the sub-epidermal cell layer ( Fig S5 D-F ), suggesting that SHR may have a non-cell-autonomous role in regulating MYB36 expression.
To determine if CIF2-induced expression and localization of ectopic CASP1 resulted in commitment to endodermal cell fate, we transferred five-day-old seedlings germinated in the presence of CIF2 to plates without CIF2 for 24h. Under these conditions, the most mature (shootward) cells retained their CASP1 expression ( Fig. 3D ). However, in a small region of the differentiated tissue closer to meristematic tissues, CASP1 became diffuse, depolarized and abundant in the epidermis (Fig. 3E ). Rootward of this region, which contains cells that were dividing prior to transfer, the root appears similar to one that is untreated with CIF2 ( Fig. 3F ). In order to understand the dynamics of CASP1 in the unstable region ( Fig. 3E ), we live imaged differentiated sub-epidermal cells of plants removed from CIF2 treatment. We saw a loss of intensity and polarity of established CASP1 in the sub-epidermal cells within this region ( Fig.   3G , Movie 2). Finally, we asked if the fate of the few cells expressing CASP1 in the epidermis layer was stable after CIF2 treatment. We found significantly fewer cells expressing CASP1 in the epidermis after 48h and 72h of CIF2 treatment ( Fig. 3H ). Taken together, these results suggest that cells no longer dividing or elongating have a narrow window in which they can reverse CASP1 expression and localization. This is similar to fate reversal in induced-pluripotent stem cells and provides evidence that expression of differentiation markers is reversible in planta
The epidermal-expression of SHR induces cortex-like supernumerary layers due to the movement of SHR within the epidermal stem cells (17, 21) . Since CIF2-induced transdifferentiation occurs in the sub-epidermal layer, this raised the possibility that SHR movement is required for trans-differentiation. To test this hypothesis, we expressed SHR in the epidermis with a nuclear localization tag to sequester it to the nucleus and inhibit movement ( Fig 4A-F) .
Consistent with our results with the non-nuclear-localized SHR, the nuclear-localized SHR lines display only a few cells in the epidermis that express or localize CASP1, lignin or suberin ( Fig.   4A -B, Fig. S7A ). Upon CIF2 treatment, 70-90% of the cells in the layer that would normally be cortex contain CASP1, lignin and suberin ( Fig. 4 D-F, Fig. S7B ), indicating trans-differentiation does not require SHR movement.
Epidermis-expressed SHR combined with CIF2 result in Casparian strip-like features, suggesting that this structure might form an impermeable barrier. We tested the effectiveness of the trans-differentiated layer to act as a symplastic barrier by measuring FDA penetration (22) and as an apoplastic barrier by propidium iodide penetration (23) . The sub-epidermal layer in both pWER::SHR-GFP alone and pWER::SHR-GFP with CIF2 had similar FDA penetration rates, suggesting that the suberin deposited in this layer is not a complete symplastic barrier (Movie S1, S2). Propidium iodide penetration was partially inhibited in the sub-epidermal celllayer ( Fig. S8A-B ), suggesting that the ectopic endodermal cell wall components form a limited barrier that is not as effective as native endodermis.
Our results establish a previously unappreciated role for receptor-like kinase signaling in stabilizing transcription networks underlying differentiation, a process that was assumed to function far downstream of the events controlled by the early "master regulator" SHR. How SHR and CIF2 can overcome native gene expression to reprogram the differentiation pathway remains a mystery. Interestingly, the formation of root hairs, a hallmark of differentiation in epidermal cells, was never observed when ectopic CASP1 was present. This may be due to expression conferred by the WER promoter, which is active in all meristematic epidermal cells but only in non-hair cells in differentiated tissue (18) . Alternatively, this may be evidence for differentiation being a mutually-exclusive process. In lines expressing SHR under the COBL9 promoter, which is active in mature hair cells (24) , no ectopic CASP1 was observed. This suggests SHR must be expressed prior to the onset of epidermal differentiation to facilitate reprogramming ( Fig. S10 A-B ). Epidermal-SHR can also induce ectopic MYB36 in sub-epidermal cells ( Fig. S6D -F) and SHR reprogramming is independent of its movement ( Fig. 4D-F) . The most parsimonious explanation for these results is that there is a mobile cue or factor downstream of SHR that activates MYB36, implying another stele-derived factor in endodermal differentiation. This is supported by a recent publication demonstrating that a stele-derived cue other than SHR can activate expression of the ground-tissue associated enhancer trap J0571 (25) . Together, these data support a model in which the primary differentiation cues for the endodermis emerge from the neighboring tissue, the stele.
There are several examples of neighboring cells providing differentiation cues in animals,
including the classic cases of TGF-ß and FGF signaling in endodermal-induction of mesoderm tissue in vertebrates as well as EGF signaling in drosophila eye development (26, 27) . Finally, we note the similarity of this reprogrammed layer to the exodermis, a waterproof sub-epidermal layer present in most vascular plants, but lacking in Arabidopsis (28) . We can only speculate that homologs of these components may play a role in exodermis formation in other species. 
Supplementary Materials:
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Clearing, staining and imaging of fixed samples: For lines in a CASP1-mCherry background, lignin was assessed by Basic Fuchsin staining as described in (31) and suberin was assessed by Fluorol Yellow staining as described in (22) . Basic Fuchsin-stained roots were imaged on a Zeiss 510 confocal using a plan apochromatic 40x objective and Fluorol-Yellow stained roots on a Leica DM5000 microscope using a 10X objective (excitation/emission parameters below). For examining CASP1 expression, five day-old roots were fixed in PFA and cleared in Clearsee as described in (32) . For lines in a CASP1-GFP background, lignin localization was assessed by combining Basic Fuchsin and ClearSee (33) . Suberin was assessed by combining Nile Red and ClearSee staining (33) . Roots were imaged on a Zeiss 880 using a 40X or 20X objective. The following are the excitation and detection parameters: calcofluor white ex 405 nm, em 425-475 nm; ex Basic Fuchsin/mCherry 561 nm, em 600-650 nm; ex Fluorol-Yellow/GFP 488nm, em 525-550 nm; ex Nile Red 561 nm, em 600-620 nm. Live-Imaging of CASP1 dynamics without CIF2 and after CIF2 treatment: Seeds were sterilized, stratified for 48h and plated on plates containing ½X MS, 1% sucrose, 1%agar with or without 100nM CIF2. At five days old, plants were removed from CIF2 and imaged on a Zeiss 880 for 16-24h on a ½X MS, 1% sucrose, 1% agar pad. FDA and Propidium Iodide Assays: Seeds were sterilized, stratified for 48h and plated on sterile ½X MS, 1% sucrose plates, with or without 100nM CIF2 and with 10µM β-estradiol for seed lines containing the XVE-inducible promoter system. At five days old, a propidium iodide assay (23) or a FDA assay (22) was conducted. FACS Sorting and RNA-sequencing: Seeds were sterilized with 3% (vol/vol) sodium hypochlorite and 0.1% Tween for 5 min and rinsed five times in sterile water. Seeds were stratified for 48h and plated on sterile 1X MS, 1% sucrose plates with or without 100nM CIF2. Roots were harvested on day 5, digested and subjected to Fluorescence Activated Cell Sorting (FACS) as described previously (34) . Total RNA was isolated using RNeasy Micro-kit (Qiagen). RNA integrity and quantity were assessed on Agilent Bioanalyzer system and QuBit, respectively (ThermoFisher Scientific). cDNA synthesis for library preparation was carried out using the SMART-Seq v4 Ultra Low Input RNA kit for Sequencing (Takara). The Low Input Library Prep Kit v2 (Takara) was used to prepare libraries for sequencing. Single-end reads were obtained using the Illumina HiSeq4000 platform at the Duke University Sequencing Core. Sequencing Analysis: All scripts for analysis can be found on github: https://github.com/cdrapek/Endodermis. Briefly, reads were aligned with TopHat and counts were normalized in EdgeR (35) . Pearson correlation among libraries and mapping statistic can be found in Table S2 . Differentially expressed gene lists (Table S1) were filtered by log-fold change with an absolutely value greater than or equal to 2, p-value of 0.01 and FDR of 0.01, aside from comparing pWER::SHR-GFP with and without CIF, in which the cut off was based solely on pvalue. PCA analysis was carried out on the top 3000 genes with the most variation. Marker Spec scores and ICI values were calculated as previously described (20) . Briefly, Spec scores were calculated from RootMap FPKM RNAseq data with the "getAllSpec" function and the default filters (medianfilter=0, cuts=FALSE, distshape=0). The index of cell identity (ICI) was calculated for each replicate using the "getIdentity" function. Values reported are for the normalized ICI score. Significance was determined from FDR corrected p-values. Transgenic lines and cloning: The following lines have been previously published: pWER::SHR-GFP, CASP1-mCherry, CASP1-GFP, SGN3:venus, SCR:CFP. For full list of primers used for cloning, see supplemental material Table S3 . The 3Kb fragment upstream of the MYB36 start codon was fused to H2B and 3xYFP fragments using the multi-site gateway system. The inducible WER-XVE promoter was previously generated (30) . This was fused to MYB36 or SCR cDNA entry vectors and fluorophore-terminator containing entry vectors using the multisite gateway system into a Norf-resistant destination vector. The SHR-mKate2 lines were generated by fusing SHR cDNA to mKate2 by In-Fusion technology (Takara) followed by insertion into pDONR221 vector by BP reaction. The pWER-XVE promoter and SHR-mKate2 construct were assembly into the FastRed selection system destination vector using the Gateway Cloning system. For each transgenic line, four to eight T1 lines containing a single-insertion were observed and a representative line was selected for follow up study. Author contributions:
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